DOES TRANSENDOCARDIAL INJECTION OF MESENCHYMAL STEM CELLS IMPROVE MYOCARDIAL FUNCTION LOCALLY, OR GLOBALLY: AN ANALYSIS FROM THE POSEIDON TRIAL

Background Transendocardial Stem Cell Injection (TESI) with mesenchymal stem cells improves left ventricular (LV) geometry in chronic ischemic cardiomyopathy, by reducing myocardial scar, LV volumes, and sphericity index.

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2013-03, Vol.61 (10), p.E1634-E1634
Main Authors: Suncion, Viky Y, Ghersin, Eduard, Zambrano, Juan Pablo, Karantalis, Vasileios, Mandel, Nicole S, Nelson, Katarina H, Fishman, Joel E, Gerstenblith, Gary, Velazquez, Darcy L. DiFede, Breton, Elayne, Schulman, Ivonne H, Sitammagari, Kranthi, Johnston, Peter V, Brinker, Jeffrey, Altman, Peter, Mushtaq, Muzammil, Trachtenberg, Barry, Silva, Jose Da, McNiece, Ian K, Lardo, Albert C, George, Richard T, Hare, Joshua M, Heldman, Alan W
Format: Article
Language:English
Subjects:
Cardiology
Cardiovascular
Heart attacks
Internal Medicine
Stem cells
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Transendocardial Stem Cell Injection (TESI) with mesenchymal stem cells improves left ventricular (LV) geometry in chronic ischemic cardiomyopathy, by reducing myocardial scar, LV volumes, and sphericity index.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(13)61634-4